Literature DB >> 32071456

[Tribbles pseudokinase 3 inhibits the adipogenic differentiation of human adipose-derived mesenchymal stem cells].

X S Bai1, L W Lv1, Y S Zhou1.   

Abstract

OBJECTIVE: To identify the role of Tribbles pseudokinase 3 (TRIB3) during the process of adipogenic differentiation of human adipose-derived mesenchymal stem cells (hASCs), and to provide a new target and a novel idea for the application of hASCs in adipose tissue engineering and soft tissue regeneration.
METHODS: TRIB3-knockdown hASCs (shTRIB3) and TRIB3-overexpression hASCs (TRIB3-over) were established using lentivirus transfection technique. The transfection effect was estimated by the visible presence of green fluorescence as the expression of green fluorescent protein (GFP) in the transfected hASCs. The lentiviral transfection efficiency was examined by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot. After adipogenic induction, Oil Red staining and quantification, as well as qRT-PCR about several specific adipogenic markers were used to evaluate the adipogenic differentiation ability of hASCs.
RESULTS: In TRIB3-knockdown hASCs, the TRIB3 mRNA expression level decreased by about 84.3% compared with the control group (P<0.01), and the TRIB3 protein level also showed obvious reduction. Oppositely, in TRIB3-overexpression hASCs, the TRIB3 mRNA expression level increased by approximately 160% compared with the control group (P<0.01), and the TRIB3 protein level also showed a significant increase. These results indicated a successful construction of TRIB3-knockdown hASCs and TRIB3-overexpression hASCs. The Oil Red staining results showed that the down-regulation of TRIB3 significantly promoted lipid droplets formation in hASCs, consistent with Oil Red quantification. On the other hand, the up-regulation of TRIB3 suppressed lipid droplets formation in hASCs, consistent with Oil Red quantification. After adipogenic induction, adipogenesis-related genes, including peroxisome proliferator-activated receptor γ (PPARγ), cluster of differentiation 36 (CD36) and CCAAT/enhancer binding protein α (C/EBPα), were increased significantly in TRIB3-knockdown hASCs compared with the control group (P<0.01). Oppositely, PPARγ, CD36 and lipoprotein lipase (LPL) were significantly decreased in TRIB3-overexpression hASCs compared with the control group (P<0.01).
CONCLUSION: TRIB3 inhibited the adipogenic differentiation of hASCs. Knockdown of TRIB3 promoted the ability of adipogenesis of hASCs, while overexpression of TRIB3 inhibited the adipogenic differentiation of hASCs. Considering the important role of PPARγ in the adipogenis process, the molecular mechanism of the regulatory function of TRIB3 may be related with PPARγ signal pathway.

Entities:  

Mesh:

Year:  2020        PMID: 32071456      PMCID: PMC7439058     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  37 in total

Review 1.  Putting the brakes on insulin signaling.

Authors:  Alan R Saltiel
Journal:  N Engl J Med       Date:  2003-12-25       Impact factor: 91.245

2.  TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism.

Authors:  Ling Qi; Jose E Heredia; Judith Y Altarejos; Robert Screaton; Naomi Goebel; Sherry Niessen; Ian X Macleod; Chong Wee Liew; Rohit N Kulkarni; James Bain; Christopher Newgard; Michael Nelson; Ronald M Evans; John Yates; Marc Montminy
Journal:  Science       Date:  2006-06-23       Impact factor: 47.728

3.  Disease status affects the association between rs4813620 and the expression of Alzheimer's disease susceptibility gene TRIB3.

Authors:  Guiyou Liu; Shuilin Jin; Yang Hu; Qinghua Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-24       Impact factor: 11.205

Review 4.  Advances in tissue engineering through stem cell-based co-culture.

Authors:  Nikolaos K Paschos; Wendy E Brown; Rajalakshmanan Eswaramoorthy; Jerry C Hu; Kyriacos A Athanasiou
Journal:  J Tissue Eng Regen Med       Date:  2014-02-03       Impact factor: 3.963

Review 5.  Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer.

Authors:  Debasis Mondal; Aditi Mathur; Partha K Chandra
Journal:  Biochimie       Date:  2016-02-06       Impact factor: 4.079

6.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

Review 7.  Mammalian Pseudokinase TRIB3 in Normal Physiology and Disease: Charting the Progress in Old and New Avenues.

Authors:  Tiit Ord; Tonis Ord
Journal:  Curr Protein Pept Sci       Date:  2017       Impact factor: 3.272

Review 8.  Targeting adipose tissue in the treatment of obesity-associated diabetes.

Authors:  Christine M Kusminski; Perry E Bickel; Philipp E Scherer
Journal:  Nat Rev Drug Discov       Date:  2016-06-03       Impact factor: 84.694

9.  MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3.

Authors:  Xing Liu; Jiejie Zhao; Qi Liu; Xuelian Xiong; Zhijian Zhang; Yang Jiao; Xiaoying Li; Bin Liu; Yao Li; Yan Lu
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

10.  A Reciprocal Role of the Smad4-Taz Axis in Osteogenesis and Adipogenesis of Mesenchymal Stem Cells.

Authors:  Jin Seok Park; Minbeom Kim; No-Joon Song; Jun-Hyeong Kim; Dongyeob Seo; Ji-Hyung Lee; Su Myung Jung; Jae Young Lee; Jaewon Lee; Youn Sook Lee; Kye Won Park; Seok Hee Park
Journal:  Stem Cells       Date:  2018-12-07       Impact factor: 6.277

View more
  1 in total

1.  Tribbles 3 deficiency promotes atherosclerotic fibrous cap thickening and macrophage-mediated extracellular matrix remodelling.

Authors:  Laura Martinez-Campesino; Klaudia Kocsy; Jaime Cañedo; Jessica M Johnston; Charlotte E Moss; Simon A Johnston; Stephen Hamby; Alison H Goodall; Jessica Redgrave; Sheila E Francis; Endre Kiss-Toth; Heather L Wilson
Journal:  Front Cardiovasc Med       Date:  2022-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.